PORTFOLIO COMPANIES




Portfolio Companies | Former Portfolio Companies

 

ExSAR (formerly Carta Proteomics) is focused on providing a technology to determine the efficient protein / protein-binding sites into a drug discovery platform. ExSAR is soon developing chaperones for diseases that are a function of misfolded proteins.(www.exsar.com)

 
 
Immunicon

Immunicon has developed and utilizes a magnetic separations technology for rare cell detection. The initial market for this technology is early detection of circulating cancer cells in blood. (www.immunicon.com)

 
 
 

PharmaStem (formerly Biocyte) is focused on sourcing stem cells from umbilical cord blood as an an important alternative to cells from bone marrow and peripheral blood for treatment of cancers, immune-specific diseases and gene therapy.

 
 
 
Sepracor

Sepracor (SEPR) is a specialty pharmaceutical company focusing on intellectual properties based on the purification of isomers and their metabolites. The Company has filed for patents on the purified forms of approximately 30 major drugs. They are marketing several of these compounds directly with major pharmaceutical companies. Sepracor markets a drug, Lunesta, for sleep directly to doctors. (www.sepracor.com)

 

 

back to top

 

Former Portfolio Companies

 
 
Targent, Inc.

Targent Inc. focuses on the repositioning and reformulation of older cancer therapeutics and is screening a range of new compounds for novel hits. Targent was sold to Spectrum Pharmaceuticals in 2006. (www.spectrumpharm.com)

 
 
 
Vela Pharmaceuticals

Vela Pharmaceuticals is focused on the identification, development, and marketing of therapeutics for psychiatric and behavioral disorders. Vela was sold to Pharmos (PARS) in 2006. (www.pharmoscorp.com)

 
 
 
i-STAT

i-STAT: (STAT) Develops and manufactures pocket-sized clinical chemistry analyzers and disposables providing accurate, real-time measurements of blood analytes for point-of-care testing. IStat was sold to Abbott Laboratories. (www.i-stat.com)

 
 
 
Envirogen Envirogen (ENVG) uses unique biotechnologies for microbial degradation of toxic waste, including PCBs and TCE, hydrocarbon remediation and developing advanced biotreatment systems for the destruction of contaminants in soils, air, and waterways. Envirogen was sold to Shaw Group. (www.shawgrp.com)
 
 
 

Sonomed is a leading manufacturer of ultrasonic diagnostic instrumentation for ophthalmic indications. Sonomed was sold to Escalon in 1999. (www.escalonmed.com)

 

 

back to top

 
 
 
home | about johnston associates inc. | our services | portfolio | contact us